Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-97-28]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for opportunity for public comment on

proposed data collection projects, the Centers for Disease Control and

Prevention (CDC) will publish periodic summaries of proposed projects.

To request more information on the proposed projects or to obtain a

copy of the data collection plans and instruments, call the CDC Reports

Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information is necessary for the proper performance of the functions of

the agency, including whether the information shall have practical

utility; (b) the accuracy of the agency's estimate of the burden of the

proposed collection of information; (c) ways to enhance the quality,

utility, and clarity of the information to be collected; and (d) ways

to minimize the burden of the collection of information on respondents,

including through the use of automated collection techniques for other

forms of information technology. Send comments to Wilma Johnson, CDC

Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA

30333. Written comments should be received within 60 days of this

notice.

Proposed Projects

1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--

Revision--The National Home and Hospice Care Survey (NHHCS) was

conducted in 1992, 1993, 1994 and 1996. It is part of the Long-Term

Care component of the National Health Care Survey. Section 306 of the

Public Health Service Act states that the National Center for Health

Statistics ``shall collect statistics on health resources * * * [and]

utilization of health care, including utilization of * * * services of

hospitals, extended care facilities, home health agencies, and other

institutions.'' NHHCS data are used to examine this most rapidly

expanding

[[Page 57437]]

sector of the health care industry. Data from the NHHCS are widely used

by the health care industry and policy makers for such diverse analyses

as the need for various medical supplies; minority access to health

care; and planning for the health care needs of the elderly. The NHHCS

also reveals detailed information on utilization patterns, as needed to

make accurate assessments of the need for and costs associated with

such care. Data from earlier NHHCS collections have been used by the

Congressional Budget Office, the Bureau of Health Professions, the

Maryland Health Resources Planning Commission, the National Association

for Home Care, and by several newspapers and journals. Additional uses

are expected to be similar to the uses of the National Nursing Home

Survey. NHHCS data cover: baseline data on the characteristics of

hospices and home health agencies in relation to their patients and

staff, Medicare and Medicaid certification, costs to patients, sources

of payment, patients' functional status and diagnoses. Data collection

is planned for the period July-October, 1997. Survey design is in

process now. Sample selection and preparation of layout forms will

precede the data collection by several months. The total cost to

respondents is estimated at $172,500.

----------------------------------------------------------------------------------------------------------------

No. of Avg. burden/ Total

Respondents No. of responses/ response burden (in

respondents respondent (in hrs.) hrs.)

----------------------------------------------------------------------------------------------------------------

Agency Questionnaire....................................... 1,200 1 0.333 400

Current Patient Sampling List.............................. 1,200 1 0.333 400

Current Patient Questionnaire.............................. 1,200 6 0.25 1,800

Discharged Patient Sampling List........................... 1,200 1 0.50 600

Discharged Patient Questionnaire........................... 1,200 6 0.25 1,800

----------------------------------------------------

Total................................................ 5,000

----------------------------------------------------------------------------------------------------------------

2. Childhood Lead Poisoning Prevention Program Quarterly Report

(0902-0282)--Extension--Lead poisoning is the most common and

societally devastating environmental disease of young children in the

United States. Severe lead exposure can cause coma, convulsions, and

even death. Lower levels of lead, which rarely cause symptoms, can

result in decreased intelligence, developmental disabilities, and

behavioral disturbances. State and community health agencies are the

principal delivery points for childhood lead screening and related

medical and environmental management activities. In FY 1996, CDC

awarded 40 grants to fund childhood lead poisoning prevention programs.

The primary purpose of these grants is for the initiation or expansion

of state- and community-based childhood lead poisoning prevention

programs that do the following: (1) screen infants and children for

elevated blood lead levels, (2) assure referral for treatment of, and

environmental intervention for, infants and children with elevated

blood lead levels, and (3) to provide education about childhood lead

poisoning. The purpose of the quarterly report is to report data

collected by CDC's grantees. The report consists of narrative and data

sections. The purpose of the narrative section is to provide the

following: (1) highlights of quarterly activities, (2) discuss issues

and activities that have significant impact on the program, (3) list

objectives and discuss progress towards meeting those objectives. The

purpose of the data section is to provide the following: (1) screening

and case confirmation activities, (2) environmental inspection and

hazard remediation activities, and (3) medical case management

activities. The total cost to the respondents is $0.00.

----------------------------------------------------------------------------------------------------------------

No. of Avg. burden/ Total

Respondents No. of responses/ response burden (in

respondents respondent (in hrs.) hrs.)

----------------------------------------------------------------------------------------------------------------

Grantees.................................................... 40 4 2 320

----------------------------------------------------------------------------------------------------------------

3. Validation of Self-Reported Health Outcomes from the Health

Assessment of Persian Gulf War Veterans From Iowa--Extension with

change--The purpose of this proposed study is to collect additional

data to validate health outcomes reported by participants in the Health

Assessment of Persian Gulf War Veterans From Iowa. The original data

collection consisted of a telephone survey of 3,695 military personnel

who served during the time of the Persian Gulf War and listed Iowa as

their home of residence. Data will be collected from subjects who

participated in the telephone survey to validate the self-report of

four health outcomes: cognitive dysfunction, depression, asthma, and

multi systemic conditions. Neuropsychological testing will be

administered to validate cognitive dysfunction. Structured clinical

interviews for mental disorders and paper-and-pencil questionnaires

will be administered to validate depression. Lung function assessment,

tests of airways hyperactivity, and standard respiratory health

questionnaires will be administered to validate asthma. Review of

medical records, standard physical examination, and laboratory

evaluation will be conducted to validate multi systemic conditions,

including chronic fatigue syndrome and fibromyalgia. In addition, a

feasibility study will be conducted to explore the usefulness of two

databases established by the Department of Defense, the Troop Exposure

Assessment Model and the Registry of Unit Locations, to validate self-

reported exposures among Persian Gulf War veterans who participated in

the Iowa telephone survey. The total cost to the respondents is $0.00.

[[Page 57438]]

----------------------------------------------------------------------------------------------------------------

No. of Avg. burden/

Respondents No. of responses/ response (in Total burden

respondents respondent hrs.) (in hrs.)

----------------------------------------------------------------------------------------------------------------

Case Validation of Cognitive Dysfunction

----------------------------------------------------------------------------------------------------------------

PGW Exposed Veterans with self- reported symptoms of

Cognitive Dysfunction. Full neuropsychological exam...... 100 1 4.0 400

Non-PGW Veterans with self-reported symptoms of Cognitive

Dysfunction. Full neuropsychological exam................ 100 1 4.0 400

Normal Controls (PGW/Non-PGW Veterans denying symptoms of

Cognitive Dysfunction). Cognitive testing................ 100 1 2.0 200

-----------------------------------------------------

Total..................................................... ........... ........... ............ 1000

----------------------------------------------------------------------------------------------------------------

Case Validation for Asthma

----------------------------------------------------------------------------------------------------------------

PGW Exposed and Non-PGW Veterans self-reporting asthma.

Questionnaire (ATS and Adult Respiratory Health);

Pulmonary Function Tests (spirometry, DLCO, lung

volumes); Histamine Challenge............................ 50 1 2.25 112.5

Normal Controls. (PGW/Non-PGW Vets denying symptoms of

asthma). Questionnaire (ATS and Adult Respiratory

Health); Pulmonary Function Tests (spirometry, DLCO, lung

volumes); Histamine Challenge............................ 50 1 2.25 112.5

-----------------------------------------------------

Total............................................... ........... ........... ............ 225

----------------------------------------------------------------------------------------------------------------

Case Validation of Depression

----------------------------------------------------------------------------------------------------------------

PGW Exposed Veterans reporting ``any type of depression.''

Questionnaire (Structured Clinical Interview and Family

History-Research Diagnostic Criteria).................... 50 1 3.0 150

Non-PGW Exposed Veterans reporting ``any type of

depression.'' Questionnaire (Structured Clinical

Interview and Family History-Research Diagnostic

Criteria)................................................ 50 1 3.0 150

-----------------------------------------------------

Total............................................... ........... ........... ............ 300

----------------------------------------------------------------------------------------------------------------

Validation of Multi-Systemic Illnesses

----------------------------------------------------------------------------------------------------------------

PGW Exposed and Non-PGW Veterans reporting symptoms of

chronic fatigue, fibromyalgia, and/or multiple chemical

sensitivity. Iowa Persian Gulf Study Questionnaire;

Physical exam............................................ 243 1 3.0 729

Normal Control (PGW/Non-PGW Veterans denying symptoms of

chronic fatigue, fibromyalgia, and/or multiple chemical

sensitivity). Iowa Persian Gulf Study Questionnaire;

Physical exam............................................ 116 1 3.0 348

-----------------------------------------------------

Total............................................... ........... ........... ............ 1077

----------------------------------------------------------------------------------------------------------------

Wilma G. Johnson,

Acting Associate Director for Policy Planning and Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 96-28502 Filed 11-5-96; 8:45 am]

BILLING CODE 4163-10-P